Rectal nitric oxide as biomarker in the treatment of inflammatory bowel disease: responders versus nonresponders.
about
Review of clinical studies of Polygonum multiflorum Thunb. and its isolated bioactive compoundseNOS involved in colitis-induced mucosal blood flow increase.Review article: the role of oxidative stress in pathogenesis and treatment of inflammatory bowel diseases.Intestinal myofibroblasts produce nitric oxide in response to combinatorial cytokine stimulationAnti-inflammatory Effect of Oyster Shell Extract in LPS-stimulated Raw 264.7 CellsNoninvasive methods in evaluation of inflammatory bowel disease: where do we stand now? An update.Molecular Alterations of Colorectal Cancer with Inflammatory Bowel Disease.Nitric oxide as a potential biomarker in inflammatory bowel disease.Proinflammatory stimuli activates human-derived enteroglial cells and induces autocrine nitric oxide production.Wnt pathway-related gene expression in inflammatory bowel disease.Cape Gooseberry [Physalis peruviana L.] Calyces Ameliorate TNBS Acid-induced Colitis in Rats.Anti-inflammatory effect and mechanism of action of Lindera erythrocarpa essential oil in lipopolysaccharide-stimulated RAW264.7 cells.Polymorphisms in oxidative pathway related genes and susceptibility to inflammatory bowel disease.Anti-inflammatory effects of phenolic compounds isolated from the flowers of Nymphaea mexicana Zucc.Fatty acids from edible sea hares: anti-inflammatory capacity in LPS-stimulated RAW 264.7 cells involves iNOS modulation
P2860
Q30408018-C28FCFD5-DC85-424D-9109-50C57D123191Q33303154-F168B595-52F3-45BD-A830-AB427D7C5B39Q33785337-E0FB698B-A2EB-415A-B389-30E3AB3BA62AQ33897529-35F54A87-6B1D-45A0-9251-F75C1386406BQ37401501-BCEEABE2-F71B-4606-8054-E5F73AF18741Q37698973-0BD483DB-6C05-4A62-925F-29545866BE64Q38404877-2959F3EE-FC98-4F84-9D6E-DB7E5351535AQ41886512-D22E83C5-9EF2-4BCC-B825-4BF80F33FA77Q44201488-DAC43F36-5DB4-4A6A-BB80-E4A35A406F54Q45980555-BA8CF96E-20AC-4986-A6AC-546F798C1B67Q46693539-A8D23D8D-53EC-4EE6-9FAA-4964F94F6C8DQ47124990-E0FD779C-9707-4E9C-BB9A-64F52F237E23Q47142282-9480654D-BFBA-48ED-9462-ACF44FE745D4Q50944696-0FB06A36-BC8E-4FCA-A117-1DBB289A534DQ57752347-F3D568CE-C26F-424F-8CD7-D5C5A8358124
P2860
Rectal nitric oxide as biomarker in the treatment of inflammatory bowel disease: responders versus nonresponders.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Rectal nitric oxide as biomark ...... sponders versus nonresponders.
@ast
Rectal nitric oxide as biomark ...... sponders versus nonresponders.
@en
type
label
Rectal nitric oxide as biomark ...... sponders versus nonresponders.
@ast
Rectal nitric oxide as biomark ...... sponders versus nonresponders.
@en
prefLabel
Rectal nitric oxide as biomark ...... sponders versus nonresponders.
@ast
Rectal nitric oxide as biomark ...... sponders versus nonresponders.
@en
P2093
P2860
P356
P1476
Rectal nitric oxide as biomark ...... esponders versus nonresponders
@en
P2093
Catharina Johansson
Jon O Lundberg
Mark Varsanyi
Max Herulf
Peter T Schmidt
Sofie Lundberg
Tryggve Ljung
P2860
P304
P356
10.3748/WJG.V12.I21.3386
P407
P577
2006-06-01T00:00:00Z